Supplier
Joint Township District Memorial Hospital
Joint Township District Memorial Hospital was paid $7.60M by Medicaid between Jan 2018 and Dec 2024, across 157 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 19% of everything it billed.
33Billing provider infoJOINT TOWNSHIP DISTRICT MEMORIAL HOSPITAL
SAINT MARYS, OH 45885
SAINT MARYS, OH 45885
33aNPI1639133002assigned 04/13/2006
33bProvider typeInstitutional Pharmacy
28Total paid$7.60M
24GClaims202,568
24DCodes billed157
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,641 | $645K | |
| 2019 | 15,564 | $603K | |
| 2020 | 12,706 | $606K | |
| 2021 | 18,538 | $798K | |
| 2022 | 18,853 | $849K | |
| 2023 | 73,426 | $2.39M | |
| 2024incomplete | 46,840 | $1.70M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 19% | 16,279 | 14,399 | $1.43M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 19% | 17,564 | 13,788 | $1.41M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 17,868 | 13,676 | $1.31M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 5.3% | 6,721 | 1,736 | $401K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4.4% | 1,391 | 781 | $337K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 3.7% | 4,527 | 1,416 | $281K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.4% | 6,652 | 5,886 | $259K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2.8% | 2,978 | 1,048 | $212K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.2% | 827 | 662 | $170K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.1% | 637 | 479 | $157K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.7% | 561 | 413 | $131K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.5% | 2,344 | 2,217 | $117K |
145 more codes
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.5% | 1,005 | $116K |
| 99285 | Emergency room visit (most serious) | 1.3% | 1,094 | $96K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.1% | 401 | $86K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.1% | 1,783 | $84K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,202 | $72K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,906 | $70K |
| G0378 | Hospital observation service, per hour | <1% | 1,064 | $65K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 3,845 | $64K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 582 | $60K |
| 87631 | <1% | 426 | $57K | |
| 80053 | Comprehensive metabolic panel | <1% | 6,791 | $49K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 6,875 | $37K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 208 | $36K |
| A0425 | Ground mileage, per statute mile | <1% | 747 | $35K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 11,978 | $27K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 388 | $26K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 988 | $25K |
| 29581 | <1% | 304 | $25K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 18,390 | $23K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,572 | $22K |
| 97161 | <1% | 542 | $18K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,214 | $18K |
| 80061 | Lipid panel | <1% | 1,068 | $15K |
| 87070 | <1% | 1,002 | $14K | |
| 84439 | <1% | 863 | $11K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 874 | $11K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 138 | $11K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 558 | $11K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,202 | $10K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 40 | $10K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,273 | $9K |
| A0426 | Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) | <1% | 146 | $9K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,865 | $9K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 426 | $8K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 280 | $8K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 385 | $8K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 306 | $7K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 298 | $7K |
| 64493 | <1% | 14 | $6K | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,437 | $5K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 28 | $4K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 420 | $4K |
| 80305 | <1% | 587 | $4K | |
| 87077 | <1% | 736 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 655 | $3K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 32 | $3K |
| 0012A | <1% | 114 | $3K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 81 | $3K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 216 | $3K |
| 81003 | <1% | 3,285 | $3K | |
| 84484 | <1% | 2,016 | $3K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 19 | $3K |
| 81001 | <1% | 1,403 | $3K | |
| 86803 | <1% | 97 | $3K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 207 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,809 | $2K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 147 | $2K |
| 0011A | <1% | 84 | $2K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 19 | $2K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,776 | $2K |
| 82570 | <1% | 323 | $2K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 34 | $2K |
| 87186 | <1% | 623 | $2K | |
| 59025 | Fetal non-stress test | <1% | 24 | $2K |
| 83690 | <1% | 1,817 | $2K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 12 | $2K |
| 82607 | <1% | 126 | $2K | |
| 87205 | <1% | 484 | $2K | |
| 94762 | <1% | 92 | $2K | |
| 83735 | <1% | 967 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 76 | $1K |
| 86140 | <1% | 85 | $1K | |
| J3490 | Unclassified drugs | <1% | 109 | $1K |
| 83880 | <1% | 530 | $1K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,742 | $1K |
| 85610 | <1% | 1,000 | $1K | |
| 74018 | <1% | 42 | $990.58 | |
| 87147 | <1% | 272 | $962.64 | |
| 84702 | <1% | 40 | $835.74 | |
| 80076 | <1% | 65 | $775.71 | |
| 82948 | <1% | 1,254 | $741.29 | |
| 85379 | <1% | 517 | $719.90 | |
| 76830 | Ultrasound, transvaginal | <1% | 13 | $714.13 |
| 87634 | <1% | 170 | $685.42 | |
| 83550 | <1% | 55 | $679.32 | |
| 97014 | <1% | 48 | $675.12 | |
| 99484 | <1% | 25 | $623.23 | |
| 83540 | <1% | 57 | $615.04 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 15 | $607.53 |
| 73610 | <1% | 82 | $588.69 | |
| 85652 | <1% | 123 | $559.89 | |
| 73630 | <1% | 90 | $525.47 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 182 | $479.18 |
| 99221 | <1% | 30 | $475.96 | |
| 73030 | <1% | 20 | $418.90 | |
| 82077 | <1% | 208 | $418.07 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,431 | $376.34 |
| 82043 | <1% | 59 | $370.41 | |
| 82728 | <1% | 19 | $353.96 | |
| 80055 | <1% | 15 | $349.68 | |
| 81025 | <1% | 1,130 | $259.50 | |
| 85730 | <1% | 233 | $249.54 | |
| 83605 | <1% | 327 | $219.12 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 602 | $211.44 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 27 | $195.75 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,455 | $194.79 |
| 80051 | <1% | 14 | $191.63 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,562 | $150.49 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 742 | $119.80 |
| 87040 | <1% | 95 | $109.83 | |
| 86901 | <1% | 14 | $97.09 | |
| 84550 | <1% | 19 | $94.48 | |
| 86900 | <1% | 14 | $80.64 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,103 | $51.07 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 184 | $45.61 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,037 | $36.13 |
| J2704 | Injection, propofol, 10 mg | <1% | 1,216 | $34.20 |
| 85027 | <1% | 17 | $31.46 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 828 | $8.56 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 22 | $3.65 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 243 | $1.89 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 210 | $1.75 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 27 | $1.13 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 601 | $0.95 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 170 | $0.41 |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 16 | $0.38 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 257 | $0.13 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 151 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 178 | $0.00 |
| 74022 | 0% | 14 | $0.00 | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 0% | 30 | $0.00 |
| 94760 | 0% | 16 | $0.00 | |
| 96376 | 0% | 282 | $0.00 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 328 | $0.00 |
| 87276 | 0% | 20 | $0.00 | |
| 64494 | 0% | 14 | $0.00 | |
| A4649 | Surgical supply; miscellaneous | 0% | 411 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 1,282 | $0.00 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 61 | $0.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 43 | $0.00 |
| 87275 | 0% | 20 | $0.00 | |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 0% | 78 | $0.00 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 0% | 15 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 12 | $0.00 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPOHL, TRICIA (CFO)
| Provider | Location | Paid |
|---|---|---|
| JTDM Family Practice LLC | St Marys, OH | $1.50M |
| Joint Township District Memorial Hospital | St Marys, OH | $272K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.